Command Palette
Search for a command to run...
Who ranks for “zepbound”
“zepbound” gets about 1M searches a month in the US. The top results are zepbound.lilly.com, drugs.com, investor.lilly.com. The median Domain Rating on page one is DR 88, and the lowest is DR 80. To rank, you need relevant backlinks from sites like these.
Stale SERP snapshot
Snapshot date: May 11, 2025. This snapshot is older than 90 days, so treat these rankings as historical.
About 22,600,000 results
Zepbound® (tirzepatide) Injectionhttps://zepbound.lilly.com
Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble ...
People also ask
- Does Zepbound work as well as Ozempic?
- How effective is Zepbound for weight loss?
- Why won't insurance cover Zepbound?
- Is Zepbound the same as Mounjaro?
Drugs.comhttps://www.drugs.com › zepbound
Feb 25, 2025: Zepbound works by reducing your appetite and making you feel full more quickly and for a longer period of time, so you eat less and lose weight.
Eli Lilly and Companyhttps://investor.lilly.com › news-release-details › fda-app...
Dec 20, 2024: Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also ...
Weight Watchershttps://www.weightwatchers.com › weight-loss-medication
Zepbound (tirzepatide) is a prescription injectable GLP-1 medication approved by the FDA for weight loss and management. See if you qualify for Zepbound!
Food and Drug Administration (.gov)https://www.fda.gov › news-events › press-announcements
Nov 8, 2023: The US Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity.
American Academy of Family Physicians | AAFPhttps://www.aafp.org › pubs › afp › issues › steps-obesi...
Jan 1, 2024: Tirzepatide is highly effective and may be considered for patients desiring significant weight loss who are able to administer weekly subcutaneous injections.
WebMDhttps://www.webmd.com › drugs › drug-187794 › details
Dec 27, 2024: Zepbound is a GIP and GLP-1 agonist. It is used to help people lose weight and to treat obstructive sleep apnea (OSA) in people with obesity.
accessdata.fda (.gov)https://www.accessdata.fda.gov › label
WARNING: RISK OF THYROID C-CELL TUMORS. See full prescribing information for complete boxed warning. • In rats, tirzepatide causes thyroid C-cell tumors.
DailyMed (.gov)https://dailymed.nlm.nih.gov › dailymed › drugInfo
ZEPBOUND (tirzepatide) injection, for subcutaneous use, contains tirzepatide, a GIP receptor and GLP-1 receptor agonist. Tirzepatide is based on the GIP ...
See Which Sites Sell Backlinks
Sign up free to see all 100 results and find which domains are already selling links. Skip the guesswork and rank faster.
See All Results. It's Free.